Core Viewpoint - The company aims to enhance its technological research and development capabilities in the energy storage sector by acquiring a 51% stake in Daren High-Tech for 74.470761 million yuan, thereby becoming a controlling subsidiary and consolidating its competitive advantage in the industry [1] Group 1 - The acquisition is intended to strengthen the company's technical research and system integration capabilities in the energy storage field [1] - The transaction aligns with the company's long-term development strategy and deepens industry chain integration [1] - By integrating Daren High-Tech's core BMS technology and quality industrial resources, the company seeks to expand its diversified industrial layout and improve its technological attributes and profit growth potential [1]

Core Viewpoint - Unisoc Microelectronics Co., Ltd. (referred to as "Unisoc") plans to acquire controlling or full ownership of Ruineng Semiconductor Technology Co., Ltd. through a combination of issuing shares and cash payments, alongside raising supporting funds, which has raised market interest regarding its strategic layout and the protection of convertible bond investors' rights [1][2]. Group 1: Acquisition Details - Unisoc intends to acquire Ruineng Semiconductor, a leading player in the domestic power semiconductor sector, which has core technological advantages in power devices and analog chips, particularly in industrial control and new energy vehicles [1][2]. - The acquisition is expected to strengthen Unisoc's position in the power semiconductor field, complementing its existing businesses in smart security chips and special integrated circuits, thereby creating synergies [1][2]. Group 2: Market Context and Implications - The semiconductor industry has seen active mergers and acquisitions globally, with domestic companies also integrating to enhance competitiveness. Unisoc's acquisition is strategically timed to seize technological advantages during an industry cycle adjustment [2][3]. - The acquisition aims to enhance Unisoc's depth in the semiconductor industry chain and market competitiveness, contributing to the self-sufficiency of the domestic power semiconductor industry and potentially driving long-term growth through business synergies [2][3]. Group 3: Convertible Bond Impact - Due to the significant asset restructuring, Unisoc's convertible bonds ("Guowei Convertible Bonds") will be suspended from conversion starting December 30, 2025, until the first trading day after the disclosure of the transaction plan, to protect investor interests [2][3]. - The suspension period is relatively short, and if the restructuring plan exceeds expectations, the value of the convertible bonds may increase alongside the underlying stock [3].

同时，自2024年6月"科创板八条"政策发布以来，板块内产业并购重组趋于踊跃，新增产业并购案例超 过160单，披露交易金额超过490亿元。其中，50单涉及现金重大收购及发行证券类交易，交易数超过发 布前各年之和的2倍，反映出产业链整合正在提速。 目前来看，科创板的投资吸引力持续增强。随着今年以来科创综指、科创民企、科创专精特新等8条新 指数的推出，板块指数总数已达33条。截至11月底，科创板已上市ETF突破100只，跟踪产品总规模超 过3100亿元，其中科创50指数境内外跟踪产品规模近1800亿元，成为机构投资者配置硬科技资产的核心 抓手。 在制度赋能方面，人才激励与产业并购成为板块驱动成长的双引擎。目前共有448家科创板公司推出了 831单股权激励计划，板块覆盖率高达76%，涵盖董事、高管、核心技术人员、核心业务人员合计约15 万人次。 （文章来源：新华财经） 新华财经上海12月30日电（记者杜康）伴随着板块上市公司数量正式扩容至600家，科创板在保持硬科 技特色的同时，正通过稳健的业绩增长和积极的投资者回报，向市场展示其高质量发展的内生动力。从 最新披露的一系列核心财务与制度数据来看，科创板已经步入业绩韧 ...

Core Insights - The chromium salt industry in China is characterized by a tightly integrated and differentiated supply chain, with chromium ore costs accounting for approximately 30% of total production costs, while domestic reserves are scarce, leading to over 95% reliance on imports [1][5][7] - China is the largest producer and consumer of chromium salts globally, with a production share of around 45%, and the market size is expected to reach 9.41 billion yuan in 2024, projected to exceed 15 billion yuan by 2030 [1][9] - The industry is transitioning towards green transformation, demand upgrades, and supply chain integration, focusing on clean processes and high-end products as the core of growth [1][12] Industry Overview - Chromium salts are inorganic chemical products primarily made from chromium ore through various chemical processes, essential in multiple sectors such as metallurgy, electroplating, leather tanning, pigments, pharmaceuticals, and environmental protection [2][3] - The classification of chromium salts is based on valence state and application, with trivalent and hexavalent chromium salts serving different industrial purposes [3][4] Supply Chain Dynamics - The upstream segment relies heavily on chromium ore, with domestic production only reaching 100,000 to 200,000 tons annually, leading to a high dependency on imports from five countries, including South Africa [5][7] - The midstream sector is focused on processing chromium ore into intermediate products, with a shift towards cleaner production methods, while downstream demand is rapidly expanding into high-end manufacturing sectors such as aerospace and renewable energy [5][8] Market Demand Trends - The global demand for chromium salts is shifting from traditional low-growth sectors to high-growth areas like metallic chromium and high-end electroplating additives, with emerging applications in aerospace and renewable energy driving significant growth [8][9] - In China, the downstream demand is characterized by a dual structure, with traditional sectors stabilizing and new sectors like electric vehicle batteries and aerospace rapidly emerging as key growth drivers [8][9] Competitive Landscape - The chromium salt industry in China is dominated by a few key players, with Zhihua Co., Galaxy Chemical, and Citic Jinzhou Metal collectively holding over 80% market share [10][11] - Leading companies are focusing on advanced production techniques and expanding into high-end applications, while smaller firms are targeting niche markets [10][11] Future Development Trends - The industry is expected to evolve around three main directions: green transformation, demand upgrades, and supply chain integration, with a strong emphasis on clean production technologies and high-value products [12][13] - The competitive focus will shift towards resource control, compliance capabilities, and technological innovation, with leading firms enhancing their market positions through strategic resource acquisitions and integrated operations [12][14]

证券日报网讯12月29日，飞荣达（300602）在互动平台回答投资者提问时表示，公司一直高度重视行业 发展与市场变化，始终以客户需求为导向，结合自身经营实际与战略目标，审慎规划未来的战略发展方 向与业务布局。公司在持续深耕主营业务，强化内生增长的同时，也将积极寻求在技术、产品等维度与 公司战略高度协同的产业链整合机会。公司将坚持围绕既定战略稳步推进，并持续探索契合公司发展方 向的新领域，为公司的长远发展注入新动能。 ...

Core Viewpoint - The company emphasizes its commitment to enhancing core competitiveness and long-term value through industry chain integration and merger decisions [1] Group 1 - The company is actively exploring and evaluating various investment opportunities, including in high-tech sectors, to achieve long-term development and maximize shareholder value [1]

（来源：中华工商时报） 转自：中华工商时报 2024年，大湾区企业镇海商会成立，远隔千里的两地紧密相拥，经贸合作与技术交流不断释放出乘数效 应；2025年，上海市镇海商会成立，沪镇两地文旅深度交融，进一步拓展合作空间……近年来，宁波市 镇海区委统战部以乡情为纽带，以创新为驱动，通过搭建平台、完善机制，拓展全国镇商"朋友圈"，为 区域经济发展注入活力。 乡情为弦，奏响镇商新韵 "无论走多远，只要听到商会之歌里熟悉的乡音，心里就格外踏实。"在粤港澳大湾区镇海商会季度论坛 现场，深圳优艾智合机器人科技有限公司合伙人张文杰感慨道。 "镇商情系家乡行"活动像一座桥梁，把游子与故土紧紧系在一起。来自上海、香港、广州、杭州等地的 镇海籍企业家回到家乡，漫步街头巷尾，参观文化景点时，既为家乡深厚的历史底蕴而自豪，更为蓬勃 的发展活力赞叹不已。 上海锦江国际旅游股份有限公司董事长、首席执行官郑蓓感言："家乡经济发展迅速，营商环境不断优 化，让我们对家乡充满信心与期待。" 平台赋能，护航发展征程 近年来，镇海区委统战部充分发挥镇商资源优势，组建了由80余名专业技术人才构成的"同心智库"。这 支智囊团活跃在北京中关村、深圳科技园等 ...

Core Viewpoint - Jinshi Resources announced its intention to acquire a stake in Zhejiang Noah Fluorochemical Co., marking a strategic extension into downstream fine fluorochemicals and an important move for value chain deepening and industry integration [1] Group 1: Company Overview - Jinshi Resources is a leading enterprise in the upstream fluorochemical sector, aiming to enhance its business model by integrating vertically from fluorite mining to hydrogen fluoride production and fine fluorochemical manufacturing [1] - The company has expanded its operations from fluorite resources to basic fluorochemical products, including anhydrous hydrogen fluoride and anhydrous aluminum fluoride, as well as downstream lithium battery materials like lithium hexafluorophosphate [1] Group 2: Acquisition Details - Jinshi Resources plans to acquire approximately 15.7147% of Noah Fluorochemical for a cash consideration of about 257 million yuan [1] - Upon completion of the transaction, Jinshi Resources will become the second-largest shareholder of Noah Fluorochemical, with a shareholding gap of only 0.1415 percentage points from the largest shareholder [1] Group 3: Market Position and Product Application - Noah Fluorochemical's fluorinated cooling liquid products are produced through chemical synthesis and have unique advantages in purification and testing technology [1] - The company’s products have been utilized by well-known domestic and international internet companies and server manufacturers, with an established annual production capacity of 5,000 tons of fluorinated liquids, ranking among the top in the domestic immersion liquid cooling market [1]

Core Viewpoint - Rhine Biotech plans to change its controlling shareholder to Guangzhou Defu Nutrition, with the resumption of trading on December 24, following a suspension since December 10 [2][5]. Shareholder Changes - On December 22, Rhine Biotech's current controlling shareholder Qin Benjun signed several agreements with Guangzhou Defu Nutrition, including a control change framework agreement and a share transfer agreement [8]. - Qin Benjun will transfer 8.09% of his shares to Guangzhou Defu Nutrition, relinquish 25.50% of his shares, and retain voting rights for 3% of his shares. The total transaction price is 646 million yuan, with a transfer price of 10.76 yuan per share, representing a premium of 23.68% over the closing price of 8.70 yuan on December 9 [8][9]. New Shareholding Structure - After the transaction, Qin Benjun will hold 28.50% of Rhine Biotech's shares and 4.14% of the voting rights, while Guangzhou Defu Nutrition will hold 8.09% of the shares and 11.17% of the voting rights [9]. Strategic Focus - Guangzhou Defu Nutrition, established on December 2, 2025, is controlled by Hou Ming and Li Zhenfu, and aims to leverage its resources in the healthcare sector to enhance Rhine Biotech's operational efficiency and governance structure [10]. Acquisition Plans - Rhine Biotech intends to expand its industry chain through acquisitions, specifically by issuing shares to purchase 80% of Beijing Jinkangpu Food Technology Co., Ltd. from Defu Jinkangpu and Xiamen Defu Jinkangpu [12]. - This acquisition will allow Rhine Biotech to extend its operations into the field of nutritional enhancers, creating a closed-loop industry chain from raw materials to formulation solutions [12]. Financial Overview of Beijing Jinkangpu - As of September 30, 2025, Beijing Jinkangpu reported total assets of 593 million yuan and net assets of 535 million yuan, with net profits of 70.27 million yuan and 40.33 million yuan for 2024 and the first three quarters of 2025, respectively [13][14]. Financial Overview of Rhine Biotech - As of September 30, 2025, Rhine Biotech's total assets were 4.985 billion yuan, and net assets were 3.162 billion yuan, with net profits of 16.3 million yuan and 70.40 million yuan for 2024 and the first three quarters of 2025, respectively [15].

Core Viewpoint - Rhein Biotech is undergoing a change in control, with its major shareholder transferring control to Guangzhou Defu Nutrition, effective from December 24, 2023, after a suspension of trading since December 10, 2023 [1][3]. Shareholder Changes - The controlling shareholder Qin Benjun signed several agreements with Guangzhou Defu Nutrition on December 22, 2023, including a framework agreement for control change and share transfer [3]. - Qin Benjun will transfer 8.09% of his shares in Rhein Biotech to Guangzhou Defu Nutrition and will relinquish voting rights for 25.50% of his shares while retaining voting rights for 3% [4]. - The total transaction value is 646 million yuan, with a share transfer price of 10.76 yuan per share, representing a premium of 23.68% over the closing price of 8.70 yuan on December 9, 2023 [4]. Post-Transaction Shareholding Structure - After the transaction, Qin Benjun will hold 28.50% of Rhein Biotech's shares and 4.14% of the voting rights, while Guangzhou Defu Nutrition will hold 8.09% of the shares and 11.17% of the voting rights [5]. - Guangzhou Defu Nutrition was established on December 2, 2025, by Defu Capital and currently has not engaged in any actual business activities [5]. Strategic Intentions - Rhein Biotech aims to leverage Defu Capital's extensive resources in the healthcare sector to enhance its operational efficiency and governance structure [6]. - The company plans to expand its industry chain through acquisitions, specifically targeting the nutritional supplement sector, to create a closed-loop supply chain from raw materials to formulation solutions [7]. Acquisition Details - Rhein Biotech has signed agreements to acquire 80% of Beijing Jinkangpu Food Technology Co., Ltd. through share issuance, which will be funded by issuing shares to Guangzhou Defu Nutrition [7]. - This acquisition is expected to enhance Rhein Biotech's capabilities in the nutritional supplement market, particularly in the area of fortified food products [8]. Financial Overview of Beijing Jinkangpu - As of September 30, 2025, Beijing Jinkangpu reported total assets of 593 million yuan and a net profit of 40.33 million yuan for the first three quarters of 2025 [8]. - The company is a leading supplier of nutritional supplements for infant formula manufacturers, indicating a strong market position [8]. Financial Performance of Rhein Biotech - As of September 30, 2025, Rhein Biotech's total assets were 4.985 billion yuan, with a net profit of 70.40 million yuan for the first three quarters of 2025 [10]. - The company has shown a consistent growth trajectory in its financial performance, with total liabilities of 1.823 billion yuan [10].